Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study.

Farhad GharibdoostAmir-Hossein SalariMansour SalesiFaegheh Ebrahimi ChaharomPeyman MottaghiMansour HosseiniMaryam SahebariMohammadali NazariniaZahra MirfeiziMohammadreza ShakibiHamidreza MoussaviMansour KarimifarKarim MowlaHadi KarimzadehNassim AnjidaniAhmadreza Jamshidi

Published in: Advances in therapy (2021)

ClinicalTrials.gov identifier NCT04582084.

Keyphrases

rheumatoid arthritis
public health
multiple sclerosis
cross sectional
juvenile idiopathic arthritis
rheumatoid arthritis patients
clinical trial
disease activity
combination therapy